Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROVENT: Aspirin and Vitamin D3 in Prostate Cancer Active Surveillance
NCT03103152Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Dec 2016
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin, vitamin d in prostate cancer (PCa), sponsored by Queen Mary University of London. Started Dec 2016; status: completed.
02
Drugs
aspirinvitamin d
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03103152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103152.